Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1999 1
2002 1
2003 1
2009 2
2014 1
2015 1
2018 2
2020 2
2021 3
2022 2
2023 5
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for pharm d for
Search for Pharm D FE instead (1 results)
Antimicrobial for 7 or 14 Days for Febrile Urinary Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Lafaurie M, Chevret S, Fontaine JP, Mongiat-Artus P, de Lastours V, Escaut L, Jaureguiberry S, Bernard L, Bruyere F, Gatey C, Abgrall S, Ferreyra M, Aumaitre H, Aparicio C, Garrait V, Meyssonnier V, Bourgarit-Durand A, Chabrol A, Piet E, Talarmin JP, Morrier M, Canoui E, Charlier C, Etienne M, Pacanowski J, Grall N, Desseaux K, Empana-Barat F, Madeleine I, Bercot B, Molina JM, Lefort A; PROSTASHORT Study Group. Lafaurie M, et al. Clin Infect Dis. 2023 Jun 16;76(12):2154-2162. doi: 10.1093/cid/ciad070. Clin Infect Dis. 2023. PMID: 36785526 Clinical Trial.
Secukinumab.
Cada DJ, Baker DE, Panther SG, PharmD KI. Cada DJ, et al. Hosp Pharm. 2015 Sep;50(8):714-27. doi: 10.1310/hpj5008-714. Epub 2015 Sep 16. Hosp Pharm. 2015. PMID: 26823621 Free PMC article.
TMPRSS2: Potential Biomarker for COVID-19 Outcomes.
Strope JD, PharmD CHC, Figg WD. Strope JD, et al. J Clin Pharmacol. 2020 Jul;60(7):801-807. doi: 10.1002/jcph.1641. Epub 2020 May 21. J Clin Pharmacol. 2020. PMID: 32437018 Free PMC article. No abstract available.
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
Jensen TO, Murray TA, Grandits GA, Jain MK, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens R, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER; ACTIV-3/TICO Study Group. Jensen TO, et al. Lancet Microbe. 2024 Jun;5(6):e559-e569. doi: 10.1016/S2666-5247(24)00015-6. Epub 2024 May 27. Lancet Microbe. 2024. PMID: 38815595 Free article. Clinical Trial.
Guidelines on critical care services and personnel: Recommendations based on a system of categorization of three levels of care.
Haupt MT, Bekes CE, Brilli RJ, Carl LC, Gray AW, Jastremski MS, Naylor DF, PharmD MR, Md AS, Wedel SK, Md MH; Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Haupt MT, et al. Crit Care Med. 2003 Nov;31(11):2677-83. doi: 10.1097/01.CCM.0000094227.89800.93. Crit Care Med. 2003. PMID: 14605541 Review.
Basis for the permeability barrier abnormality in lamellar ichthyosis.
Elias PM, Schmuth M, Uchida Y, Rice RH, Behne M, Crumrine D, Feingold KR, Holleran WM, Pharm D. Elias PM, et al. Among authors: pharm d. Exp Dermatol. 2002 Jun;11(3):248-56. doi: 10.1034/j.1600-0625.2001.110308.x. Exp Dermatol. 2002. PMID: 12102664
25 results